Revision of David Grainger
syncWikidata syncChanges
| Field | Before | After |
|---|---|---|
| Description | — | David Grainger is a partner at medicxi, a European life sciences-oriented venture capital firm and chief executive officer of Methuselah Health Ltd., a drug development company doing proteomics research in the longevity space. |
| Type | — | person |